Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohtaro Fujihashi

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Expert Review of Vaccines|September 3, 2009
Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccinesKosuke Kataoka, Kohtaro Fujihashi
Current Opinion in Gastroenterology|October 21, 2006
Type 1 and 2 T helper cell-mediated colitisTaeko Dohi, Kohtaro Fujihashi
Trends in Immunology|June 23, 2009
Mucosal immunosenescence: new developments and vaccines to control infectious diseasesKohtaro Fujihashi, Hiroshi Kiyono
Plos Biology|October 11, 2012
Inside the mucosal immune systemJerry R McGhee, Kohtaro Fujihashi
Mechanisms of Ageing and Development|November 27, 2004
Mucosal immunity and tolerance in the elderlyKohtaro Fujihashi, Jerry R McGhee
Gerontology|December 23, 2014
Mucosal Immunosenescence in the Gastrointestinal Tract: A Mini-ReviewShintaro Sato, Hiroshi Kiyono, Kohtaro Fujihashi
Periodontology 2000|August 18, 2010
Mucosal regulatory cells in the gastrointestinal tract and periodontiumIchiro Takahashi, Kohtaro Fujihashi, Hiroshi Kiyono
Experimental Gerontology|January 21, 2014
Mucosal adjuvants for vaccines to control upper respiratory infections in the elderlyKohtaro Fujihashi, Shintaro Sato, Hiroshi Kiyono
International Immunology|August 26, 2021
Mucosal vaccines: wisdom from now and thenHiroshi Kiyono, Yoshikazu Yuki, Rika Nakahashi-Ouchida, et al.
Plos One|November 17, 2011
Functional transforming growth factor-β receptor type II expression by CD4+ T cells in Peyer's patches is essential for oral tolerance inductionRebekah S Gilbert, Ryoki Kobayashi, Shinichi Sekine, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Expert Review of Vaccines|September 3, 2009
Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccinesKosuke Kataoka, Kohtaro Fujihashi
Current Opinion in Gastroenterology|October 21, 2006
Type 1 and 2 T helper cell-mediated colitisTaeko Dohi, Kohtaro Fujihashi
Trends in Immunology|June 23, 2009
Mucosal immunosenescence: new developments and vaccines to control infectious diseasesKohtaro Fujihashi, Hiroshi Kiyono
Plos Biology|October 11, 2012
Inside the mucosal immune systemJerry R McGhee, Kohtaro Fujihashi
Mechanisms of Ageing and Development|November 27, 2004
Mucosal immunity and tolerance in the elderlyKohtaro Fujihashi, Jerry R McGhee
Gerontology|December 23, 2014
Mucosal Immunosenescence in the Gastrointestinal Tract: A Mini-ReviewShintaro Sato, Hiroshi Kiyono, Kohtaro Fujihashi
Periodontology 2000|August 18, 2010
Mucosal regulatory cells in the gastrointestinal tract and periodontiumIchiro Takahashi, Kohtaro Fujihashi, Hiroshi Kiyono
Experimental Gerontology|January 21, 2014
Mucosal adjuvants for vaccines to control upper respiratory infections in the elderlyKohtaro Fujihashi, Shintaro Sato, Hiroshi Kiyono
International Immunology|August 26, 2021
Mucosal vaccines: wisdom from now and thenHiroshi Kiyono, Yoshikazu Yuki, Rika Nakahashi-Ouchida, et al.
Plos One|November 17, 2011
Functional transforming growth factor-β receptor type II expression by CD4+ T cells in Peyer's patches is essential for oral tolerance inductionRebekah S Gilbert, Ryoki Kobayashi, Shinichi Sekine, et al.
Pageof 9